In a study examining the role of OPG and TRAIL in CAD, patients with AMI and CAD had higher levels of circulating OPG and lower levels of TRAIL compared to patients with stable CAD or healthy controls, which was aggravated as the number of affected coronary vessels increased (Shaker et al., 2010). This evidence concerns the gene TNFSF10 and coronary artery disorder.